06/17/2020
4:08 PM | Eiger Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/23/2020
7:11 AM | Eiger Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/17/2020
4:17 PM | Dietz Thomas John (Reporting)
Eiger Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2020
4:16 PM | Eiger Biopharmaceuticals (Issuer)
Glenn Jeffrey S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2020
4:40 PM | Eiger Biopharmaceuticals (Issuer)
Shaffer James P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2020
4:38 PM | Eiger Biopharmaceuticals (Issuer)
Sachdev Amit (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2020
4:35 PM | Eiger Biopharmaceuticals (Issuer)
Ryali Sriram (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2020
4:30 PM | Eiger Biopharmaceuticals (Issuer)
Patton Stephana Eilene (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2020
4:29 PM | Eiger Biopharmaceuticals (Issuer)
Murray Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2020
4:25 PM | Eiger Biopharmaceuticals (Issuer)
Glenn Jeffrey S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/13/2020
4:23 PM | Cory David A (Reporting)
Eiger Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2020
4:22 PM | Dietz Thomas John (Reporting)
Eiger Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2020
4:20 PM | Apelian David (Reporting)
Eiger Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2020
7:31 AM | Eiger Biopharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/13/2020
7:12 AM | Eiger Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2020
1:29 PM | EcoR1 Capital, LLC (Filed by)
Eiger Biopharmaceuticals (Subject)
| Form SC 13G/A
| |
01/31/2020
6:33 PM | Eiger Biopharmaceuticals (Issuer)
Mayer Eldon C. III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2020
3:44 PM | Eiger Biopharmaceuticals (Issuer)
Mayer Eldon C. III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2020
7:17 AM | Dietz Thomas John (Reporting)
Eiger Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2020
7:10 AM | Eiger Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/06/2020
7:13 AM | Eiger Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/01/2020
11:15 PM | Eiger Biopharmaceuticals (Filer)
| Form EFFECT
| |
12/20/2019
3:51 PM | Eiger Biopharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
12/16/2019
4:18 PM | Eiger Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/18/2019
4:27 PM | Eiger Biopharmaceuticals (Subject)
Vivo Ventures VI, LLC (Filed by)
| Form SC 13D/A
| |
11/07/2019
3:21 PM | Eiger Biopharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2019
3:12 PM | Eiger Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/06/2019
5:37 PM | Eiger Biopharmaceuticals (Issuer)
Shaffer James P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2019
4:47 PM | Eiger Biopharmaceuticals (Issuer)
Ryali Sriram (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2019
4:46 PM | Cory David A (Reporting)
Eiger Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2019
4:30 PM | Eiger Biopharmaceuticals (Filer)
| Form 8-K/A
| |
08/08/2019
3:31 PM | Eiger Biopharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2019
3:16 PM | Eiger Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2019
3:26 PM | Broadfin Capital, LLC (Filed by)
Eiger Biopharmaceuticals (Subject)
| Form SC 13G
| |
06/12/2019
3:33 PM | Eiger Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/30/2019
4:38 PM | Eiger Biopharmaceuticals (Issuer)
Sachdev Amit (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2019
4:35 PM | Eiger Biopharmaceuticals (Issuer)
Sachdev Amit (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/17/2019
3:15 PM | Eiger Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2019
3:17 PM | Eiger Biopharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/26/2019
3:54 PM | Cory David A (Reporting)
Eiger Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/26/2019
3:34 PM | Eiger Biopharmaceuticals (Filer)
| Form DEFA14A
| |
04/26/2019
3:31 PM | Eiger Biopharmaceuticals (Filer)
| Form DEF 14A
| |
04/23/2019
5:53 PM | Dietz Thomas John (Reporting)
Eiger Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/22/2019
8:34 PM | Eiger Biopharmaceuticals (Issuer)
Ryali Sriram (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/22/2019
8:34 PM | Dietz Thomas John (Reporting)
Eiger Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/22/2019
8:31 PM | Eiger Biopharmaceuticals (Issuer)
Patton Stephana Eilene (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/22/2019
3:35 PM | Eiger Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/18/2019
3:32 PM | Eiger Biopharmaceuticals (Filer)
| Form 424B5
| |
04/17/2019
3:07 PM | Eiger Biopharmaceuticals (Filer)
| Form 424B5
| |
04/15/2019
3:16 PM | Eiger Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/26/2019
9:22 AM | Apelian David (Reporting)
Eiger Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2019
9:12 AM | Eiger Biopharmaceuticals (Issuer)
Shaffer James P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2019
9:07 AM | Cory David A (Reporting)
Eiger Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2019
9:02 AM | Eiger Biopharmaceuticals (Issuer)
Murray Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2019
9:00 PM | Eiger Biopharmaceuticals (Issuer)
Mayer Eldon C. III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2019
8:53 PM | Dietz Thomas John (Reporting)
Eiger Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2019
8:51 PM | Eiger Biopharmaceuticals (Issuer)
Glenn Jeffrey S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2019
8:50 PM | Eiger Biopharmaceuticals (Issuer)
Loh Evan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2019
8:46 PM | Eiger Biopharmaceuticals (Issuer)
Patton Stephana Eilene (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2019
8:45 PM | Eiger Biopharmaceuticals (Issuer)
Patton Stephana Eilene (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/14/2019
4:14 PM | Eiger Biopharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/08/2019
4:19 PM | Eiger Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2019
3:25 PM | Eiger Biopharmaceuticals (Subject)
HBM Healthcare Investments Ltd. (0001232258) (Filed by)
| Form SC 13G/A
| |
02/14/2019
2:30 PM | Eiger Biopharmaceuticals (Subject)
Vivo Ventures VI, LLC (Filed by)
| Form SC 13D/A
| |
02/14/2019
1:27 PM | EcoR1 Capital, LLC (Filed by)
Eiger Biopharmaceuticals (Subject)
| Form SC 13G/A
| |
02/14/2019
8:08 AM | Eiger Biopharmaceuticals (Subject)
Prosight Management, LP (Filed by)
| Form SC 13G/A
| |
02/13/2019
4:05 PM | Eiger Biopharmaceuticals (Subject)
SPHERA FUNDS MANAGEMENT LTD. (Filed by)
| Form SC 13G/A
| |
02/07/2019
7:40 AM | Eiger Biopharmaceuticals (Subject)
PRUDENTIAL FINANCIAL INC (Filed by)
PRUDENTIAL FINANCIAL INC (Filed by)
| Form SC 13G/A
| |
02/06/2019
6:23 PM | Cory David A (Reporting)
Eiger Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2019
3:08 PM | Eiger Biopharmaceuticals (Subject)
INTERWEST PARTNERS X LP (Filed by)
| Form SC 13D/A
| |
01/31/2019
11:16 AM | Eiger Biopharmaceuticals (Subject)
JENNISON ASSOCIATES LLC (Filed by)
| Form SC 13G/A
| |
01/29/2019
2:23 PM | Eiger Biopharmaceuticals (Subject)
INTERWEST PARTNERS X LP (Filed by)
| Form SC 13D/A
| |
01/09/2019
3:15 PM | Eiger Biopharmaceuticals (Issuer)
Murray Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2019
3:12 PM | Eiger Biopharmaceuticals (Issuer)
Murray Christine (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/07/2019
3:05 PM | Eiger Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2019
4:51 PM | Eiger Biopharmaceuticals (Issuer)
Ryali Sriram (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2018
1:12 PM | Eiger Biopharmaceuticals (Issuer)
Ryali Sriram (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/20/2018
7:29 PM | Dietz Thomas John (Reporting)
Eiger Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2018
3:05 PM | Dietz Thomas John (Reporting)
Eiger Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2018
4:26 PM | Eiger Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/30/2018
1:26 PM | Eiger Biopharmaceuticals (Issuer)
Mayer Eldon C. III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/28/2018
7:51 PM | Eiger Biopharmaceuticals (Issuer)
Mayer Eldon C. III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/09/2018
3:01 PM | Eiger Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/26/2018
2:11 PM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Eiger Biopharmaceuticals (Subject)
| Form SC 13G
| |
10/25/2018
4:20 PM | Eiger Biopharmaceuticals (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, LLC (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/25/2018
4:19 PM | Eiger Biopharmaceuticals (Subject)
RA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13G
| |
10/24/2018
5:07 AM | Eiger Biopharmaceuticals (Subject)
INTERWEST PARTNERS X LP (Filed by)
| Form SC 13D/A
| |
10/23/2018
4:21 PM | Eiger Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/23/2018
4:12 PM | Eiger Biopharmaceuticals (Filer)
| Form 424B5
| |
10/22/2018
3:50 PM | Eiger Biopharmaceuticals (Filer)
| Form 424B5
| |
10/22/2018
3:33 PM | Desai Keval (Reporting)
Eiger Biopharmaceuticals (Issuer)
InterWest Management Partners X, LLC (Reporting)
INTERWEST PARTNERS X LP (Reporting)
Kliman Gilbert H (Reporting)
NASR KHALED (Reporting)
ORONSKY ARNOLD L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/22/2018
3:03 PM | Eiger Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/20/2018
11:48 AM | Eiger Biopharmaceuticals (Filer)
| Form CT ORDER
| |
08/16/2018
3:18 PM | Eiger Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2018
3:48 PM | Eiger Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/10/2018
6:31 AM | Eiger Biopharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/11/2018
4:14 PM | Eiger Biopharmaceuticals (Filer)
| Form DEFA14A
| |
06/04/2018
3:03 PM | EcoR1 Capital, LLC (Filed by)
Eiger Biopharmaceuticals (Subject)
| Form SC 13G
| |
05/25/2018
3:43 PM | Eiger Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/25/2018
3:41 PM | Eiger Biopharmaceuticals (Filer)
| Form 424B5
| |
